⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum
globenewswire.com
NVS
LLY
BOOST Pharma Appoints Leading Biopharma Leader Elaine Jones as Chair
globenewswire.com
PFE
NVS
Bringing His On-Screen Journey to Life, Ricco Ross of Tyler Perry's Netflix Series 'Beauty in Black' Joins ZERO Prostate Cancer as Global Ambassador
prnewswire.com
NVS
Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy
prnewswire.com
NVS
AZN
Nasal Mucosa Therapeutics Market Forecast 2026-2036: Market to Reach USD 31.7 Billion by 2036 at 18.3% CAGR
accessnewswire.com
GSK
JNJ
PFE
AZN
APT
NVS
LLY
Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
globenewswire.com
NVS
MRK
ARGX
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
globenewswire.com
NVS
Pharmaceuticals, Biotechnology and Diagnostics M&A Agreements Report/Directory 2026: Analyse 2,500+ Deals Signed Since 2021 - Company A-Z, Therapeutic Area, Technology Type, and Industry Segment
globenewswire.com
JNJ
NVS
Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight USA - English USA - español USA - Deutsch
prnewswire.com
NVS
LLY
AZN
Novo Holdings announces 2025 Annual Results
globenewswire.com
NVO
NVS
EVTC